Kyowa Hakko Kirin is a holding company primarily engaged in the management of its pharmaceutical-related business, as well as of its integrated group companies. Under the Kyowa Hakko Kirin Group umbrella, Kyowa Hakko Bio is responsible for our business activities in the fields of biochemical fields.
Kyowa Hakko Kirin
Kyowa Hakko Kirin’s core competency is its expertise in leading-edge biotechnology and antibodies. Using these strengths, we continually work to discover innovative new medicines in our chosen therapeutic areas of oncology, nephrology and immunology/allergy, and to bring these products to the global markets. As a Japan-based specialty pharmaceutical company with global aspirations, we aim to make a real difference to healthcare and to peoples’ lives around the world.
Kyowa Medex manufactures and sells in vitro diagnostics (clinical laboratory test drugs) and analytical equipment used by medical institutions. It also conducts mycotoxin analysis and other assays on a consignment basis. Through these activities, Kyowa Medex contributes to promoting the health and well-being of people for the future.
- Website: Kyowa Medex
Kyowa Hakko Bio
Taking advantage of our technological edge in fermentation and synthesis processes, Kyowa Hakko Bio supplies global markets with a broad array of products including amino acids (peptides), nucleic acids, vitamins and sugars (sugar nucleotides and oligosaccharides), which are in turn used by our customers to produce pharmaceuticals, health foods, foods, cosmetics and other products that demand safe high-quality raw materials. Pouring their efforts into various amino acid-related and nucleic acid-related substances and other core products targeted at high value-added medical care and health applications, Kyowa Hakko Bio have established a global system of production and marketing.
- Website: Kyowa Hakko Bio